5-[(6-amino-3-pyridinyl)methyl]-3-but-2-ynyl-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3,5-dicyano-N-methylbenzamide;tetrakis(2,2,2-trifluoroacetic acid)

C99H100F13N33O16 — CID 160535398

IUPAC5-[(6-amino-3-pyridinyl)methyl]-3-but-2-ynyl-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3,5-dicyano-N-methylbenzamide;tetrakis(2,2,2-trifluoroacetic acid)
SMILESCC#CCn1c(N2CCNCC2)nc2cnn(Cc3c(C#N)cc(C(=O)NC)cc3C#N)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(Cc3c(C#N)cc(C(=O)NC)cc3OCC)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(Cc3c(F)cc(C(=O)NC)cc3C#N)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(Cc3ccc(N)nc3)c(=O)c21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
InChIInChI=1S/C25H28N8O3.C24H23N9O2.C23H23FN8O2.C19H22N8O.4C2HF3O2/c1-4-6-9-32-22-20(30-25(32)31-10-7-28-8-11-31)15-29-33(24(22)35)16-19-18(14-26)12-17(23(34)27-3)13-21(19)36-5-2;1-3-4-7-32-21-20(30-24(32)31-8-5-28-6-9-31)14-29-33(23(21)35)15-19-17(12-25)10-16(22(34)27-2)11-18(19)13-26;1-3-4-7-31-20-19(29-23(31)30-8-5-27-6-9-30)13-28-32(22(20)34)14-17-16(12-25)10-15(11-18(17)24)21(33)26-2;1-2-3-8-26-17-15(24-19(26)25-9-6-21-7-10-25)12-23-27(18(17)28)13-14-4-5-16(20)22-11-14;4*3-2(4,5)1(6)7/h12-13,15,28H,5,7-11,16H2,1-3H3,(H,27,34);10-11,14,28H,5-9,15H2,1-2H3,(H,27,34);10-11,13,27H,5-9,14H2,1-2H3,(H,26,33);4-5,11-12,21H,6-10,13H2,1H3,(H2,20,22);4*(H,6,7)
InChIKeyFQPPKVDZVOGUOI-UHFFFAOYSA-N
MW2255.08 g/mol
LogP3.91
Rot. Bonds21

About 5-[(6-amino-3-pyridinyl)methyl]-3-but-2-ynyl-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3,5-dicyano-N-methylbenzamide;tetrakis(2,2,2-trifluoroacetic acid)

5-[(6-amino-3-pyridinyl)methyl]-3-but-2-ynyl-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3,5-dicyano-N-methylbenzamide;tetrakis(2,2,2-trifluoroacetic acid) (PubChem CID 160535398) has the molecular formula C99H100F13N33O16 and a molecular weight of 2255.08 g/mol. Its IUPAC name is 5-[(6-amino-3-pyridinyl)methyl]-3-but-2-ynyl-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3,5-dicyano-N-methylbenzamide;tetrakis(2,2,2-trifluoroacetic acid).

Molecular Properties

Compound Name5-[(6-amino-3-pyridinyl)methyl]-3-but-2-ynyl-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3,5-dicyano-N-methylbenzamide;tetrakis(2,2,2-trifluoroacetic acid)
PubChem CID160535398
Molecular FormulaC99H100F13N33O16
Molecular Weight2255.08 g/mol
Exact Mass2253.78
IUPAC Name5-[(6-amino-3-pyridinyl)methyl]-3-but-2-ynyl-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3,5-dicyano-N-methylbenzamide;tetrakis(2,2,2-trifluoroacetic acid)
SMILESCC#CCn1c(N2CCNCC2)nc2cnn(Cc3c(C#N)cc(C(=O)NC)cc3C#N)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(Cc3c(C#N)cc(C(=O)NC)cc3OCC)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(Cc3c(F)cc(C(=O)NC)cc3C#N)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(Cc3ccc(N)nc3)c(=O)c21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
InChIInChI=1S/C25H28N8O3.C24H23N9O2.C23H23FN8O2.C19H22N8O.4C2HF3O2/c1-4-6-9-32-22-20(30-25(32)31-10-7-28-8-11-31)15-29-33(24(22)35)16-19-18(14-26)12-17(23(34)27-3)13-21(19)36-5-2;1-3-4-7-32-21-20(30-24(32)31-8-5-28-6-9-31)14-29-33(23(21)35)15-19-17(12-25)10-16(22(34)27-2)11-18(19)13-26;1-3-4-7-31-20-19(29-23(31)30-8-5-27-6-9-30)13-28-32(22(20)34)14-17-16(12-25)10-15(11-18(17)24)21(33)26-2;1-2-3-8-26-17-15(24-19(26)25-9-6-21-7-10-25)12-23-27(18(17)28)13-14-4-5-16(20)22-11-14;4*3-2(4,5)1(6)7/h12-13,15,28H,5,7-11,16H2,1-3H3,(H,27,34);10-11,14,28H,5-9,15H2,1-2H3,(H,27,34);10-11,13,27H,5-9,14H2,1-2H3,(H,26,33);4-5,11-12,21H,6-10,13H2,1H3,(H2,20,22);4*(H,6,7)
InChIKeyFQPPKVDZVOGUOI-UHFFFAOYSA-N
XLogP3.91
TPSA651.72 Ų
H-Bond Donors12
H-Bond Acceptors42
Rotatable Bonds21
Heavy Atoms161
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002255.08
LogP ≤ 53.91
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1042

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze 5-[(6-amino-3-pyridinyl)methyl]-3-but-2-ynyl-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3,5-dicyano-N-methylbenzamide;tetrakis(2,2,2-trifluoroacetic acid) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[(6-amino-3-pyridinyl)methyl]-3-but-2-ynyl-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3,5-dicyano-N-methylbenzamide;tetrakis(2,2,2-trifluoroacetic acid)?
The IUPAC name of 5-[(6-amino-3-pyridinyl)methyl]-3-but-2-ynyl-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3,5-dicyano-N-methylbenzamide;tetrakis(2,2,2-trifluoroacetic acid) (CID 160535398) is 5-[(6-amino-3-pyridinyl)methyl]-3-but-2-ynyl-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3,5-dicyano-N-methylbenzamide;tetrakis(2,2,2-trifluoroacetic acid).
What is the SMILES notation for 5-[(6-amino-3-pyridinyl)methyl]-3-but-2-ynyl-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3,5-dicyano-N-methylbenzamide;tetrakis(2,2,2-trifluoroacetic acid)?
The canonical SMILES for 5-[(6-amino-3-pyridinyl)methyl]-3-but-2-ynyl-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3,5-dicyano-N-methylbenzamide;tetrakis(2,2,2-trifluoroacetic acid) is CC#CCn1c(N2CCNCC2)nc2cnn(Cc3c(C#N)cc(C(=O)NC)cc3C#N)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(Cc3c(C#N)cc(C(=O)NC)cc3OCC)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(Cc3c(F)cc(C(=O)NC)cc3C#N)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(Cc3ccc(N)nc3)c(=O)c21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.
What is the InChIKey of 5-[(6-amino-3-pyridinyl)methyl]-3-but-2-ynyl-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3,5-dicyano-N-methylbenzamide;tetrakis(2,2,2-trifluoroacetic acid)?
The InChIKey is FQPPKVDZVOGUOI-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H28N8O3.C24H23N9O2.C23H23FN8O2.C19H22N8O.4C2HF3O2/c1-4-6-9-32-22-20(30-25(32)31-10-7-28-8-11-31)15-29-33(24(22)35)16-19-18(14-26)12-17(23(34)27-3)13-21(19)36-5-2;1-3-4-7-32-21-20(30-24(32)31-8-5-28-6-9-31)14-29-33(23(21)35)15-19-17(12-25)10-16(22(34)27-2)11-18(19)13-26;1-3-4-7-31-20-19(29-23(31)30-8-5-27-6-9-30)13-28-32(22(20)34)14-17-16(12-25)10-15(11-18(17)24)21(33)26-2;1-2-3-8-26-17-15(24-19(26)25-9-6-21-7-10-25)12-23-27(18(17)28)13-14-4-5-16(20)22-11-14;4*3-2(4,5)1(6)7/h12-13,15,28H,5,7-11,16H2,1-3H3,(H,27,34);10-11,14,28H,5-9,15H2,1-2H3,(H,27,34);10-11,13,27H,5-9,14H2,1-2H3,(H,26,33);4-5,11-12,21H,6-10,13H2,1H3,(H2,20,22);4*(H,6,7).
What are the key properties of 5-[(6-amino-3-pyridinyl)methyl]-3-but-2-ynyl-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3,5-dicyano-N-methylbenzamide;tetrakis(2,2,2-trifluoroacetic acid)?
5-[(6-amino-3-pyridinyl)methyl]-3-but-2-ynyl-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3,5-dicyano-N-methylbenzamide;tetrakis(2,2,2-trifluoroacetic acid) has a molecular weight of 2255.08 g/mol, XLogP of 3.91, 21 rotatable bonds, 12 hydrogen bond donors, and 42 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[(6-amino-3-pyridinyl)methyl]-3-but-2-ynyl-2-piperazin-1-ylimidazo[4,5-d]pyridazin-4-one;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3,5-dicyano-N-methylbenzamide;tetrakis(2,2,2-trifluoroacetic acid) is sourced from PubChem (CID 160535398), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).